Palvella Therapeutics, Inc. (PVLA) Return on equity 2016–2021
Palvella Therapeutics, Inc. (PVLA) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-90.1%FY2021 · since FY2016: -90.4% → -90.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2021 | -90.1% | +29.9 pp |
| FY2020 | -120.0% | -70.4 pp |
| FY2019 | -49.6% | +17.4 pp |
| FY2018 | -67.0% | +86.2 pp |
| FY2017 | -153.2% | -62.8 pp |
| FY2016 | -90.4% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More PVLA financial trends
PVLA RevenuePVLA Net incomePVLA Net marginPVLA Gross profitPVLA Gross marginPVLA Operating incomePVLA Operating marginPVLA Operating cash flowPVLA Free cash flowPVLA Capital expendituresPVLA Stock buybacksPVLA Dividends paidPVLA Total assetsPVLA Total liabilitiesPVLA Shareholders’ equityPVLA overview →